Assembly Concurrent Resolution 146 declares March 2026 as Bleeding Disorders Awareness Month in California and frames the month as an opportunity to increase public understanding of inheritable bleeding disorders.
The resolution is ceremonial: it records findings about harms, treatment benefits, and past blood-supply contamination, and asks the Chief Clerk to distribute copies. It does not appropriate funds or change regulatory authority, but it can be used by advocates and treatment centers to coordinate outreach and education efforts.
At a Glance
What It Does
The resolution records legislative findings about hemophilia, von Willebrand disease, and related conditions, and formally designates March 2026 as an awareness month. It contains no funding provisions and imposes no regulatory or enforcement obligations; it simply requests that the Chief Clerk transmit copies for distribution.
Who It Affects
Directly relevant stakeholders include people living with inheritable bleeding disorders, federally recognized hemophilia treatment centers, patient advocacy organizations, and public health communicators who run outreach and screening efforts. It does not create new duties for regulated entities or state agencies beyond routine administrative distribution.
Why It Matters
By providing an official, statewide platform, the resolution can amplify patient outreach, encourage referrals to specialized treatment centers, and elevate prevention and education messages; however, its impact depends on subsequent action by advocates, providers, and local public health partners rather than on state funding or mandate.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The text compiles a set of findings: it describes the clinical harms of untreated bleeding disorders, notes treatment can substantially reduce morbidity and mortality, and recounts the historical contamination of the blood supply that infected many patients in the 1980s. It emphasizes the role of comprehensive care—particularly visits to federally recognized hemophilia treatment centers—in improving outcomes, and notes prior California laws demonstrating state interest in proper care and treatment.
The resolution itself functions as symbolic recognition. It does not create programs, change benefits, or direct spending.
Instead, it memorializes the Legislature’s support for awareness and community-building and provides an occasion for public-health messaging, fundraising, and service coordination led by non‑state stakeholders.Practically, the resolution gives advocacy groups and clinical providers a dated, state‑level platform to organize events, run education campaigns, and request improved access or services from local agencies. Because the measure includes no enforcement language or appropriation, any material changes—expanded clinic hours, increased staffing, or new subsidy programs—would require separate legislation or budget action.Finally, the resolution’s reference to past blood‑supply contamination implicitly underscores unresolved public-health and liability questions for affected communities, but the document stops short of establishing remedies, monitoring, or data collection obligations that would translate history into policy changes.
The Five Things You Need to Know
The resolution is ceremonial: it contains no appropriation, regulatory directive, or enforcement mechanism.
The bill cites federally recognized hemophilia treatment centers as reducing morbidity and mortality and elevates referrals to these centers as a practical goal.
The text notes past contamination of the blood supply in the 1980s that infected many with HIV and hepatitis C, framing historical harm as part of the awareness rationale.
The resolution records specific clinical consequences of untreated bleeding disorders — recurrent joint bleeding, chronic arthropathy, internal organ and brain hemorrhage leading to disability or death.
The measure instructs the Chief Clerk of the Assembly to transmit copies of the resolution to the author for appropriate distribution, a routine logistical step that creates no fiscal obligation.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings framing the awareness month
The preamble collects factual statements: it summarizes clinical features of hemophilia and related disorders, refers to the past contamination of blood products, and asserts that comprehensive care improves outcomes. These findings form the justification for the proclamation and can be quoted by advocacy campaigns; they do not create legal duties or standards of care.
Ceremonial designation
This clause formally designates March 2026 as Bleeding Disorders Awareness Month in California. As a concurrent resolution, it expresses the Legislature’s sentiment without altering statutes or appropriations. Organizations typically use such declarations as a communications anchor for events, but public agencies are not required to act.
Administrative transmission
This short clause directs the Chief Clerk to send copies of the resolution to the author for distribution. That instruction is administrative and customary; it is effectively a logistical step to make the resolution available to stakeholders and the public and does not create a new program, reporting requirement, or funding line.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People living with inheritable bleeding disorders — the public recognition can reduce stigma, increase public awareness of symptoms, and support outreach that leads to earlier diagnosis and referrals.
- Hemophilia treatment centers (HTCs) — the resolution gives HTCs a statewide platform for education and fundraising, which can help drive patient referrals and community partnerships.
- Patient advocacy organizations — the proclamation provides a dated, authoritative tool for media outreach, volunteer recruitment, and coalition-building with health departments and providers.
Who Bears the Cost
- State legislature and Chief Clerk — minimal administrative costs and staff time to process and distribute copies, absorbed within routine operations.
- Federally recognized HTCs and local providers — potential operational strain if awareness campaigns drive increased demand for specialty services without accompanying funding or workforce expansion.
- Local public-health offices and non‑profits — expectation to participate in outreach events and campaigns that may require reallocation of existing limited resources.
Key Issues
The Core Tension
The central tension is symbolic recognition versus substantive change: the resolution signals legislative attention and can galvanize outreach, but without funding, mandates, or data collection it cannot resolve access, capacity, or compensation issues that many people with bleeding disorders face—so it raises expectations that require separate, concrete policy action to meet.
The resolution trades symbolic recognition for no direct policy or funding change. That makes it useful for awareness and advocacy but ineffective at addressing structural gaps such as geographic disparities in access to specialized hemophilia care, workforce shortages at treatment centers, or costs of factor replacement therapies.
A further implementation risk: successful awareness activities can increase demand for diagnostic workups and clinic visits; without parallel funding or capacity expansion, patients may face waitlists or incomplete follow‑through. The text also highlights historical blood‑supply contamination but does not establish mechanisms for surveillance, compensation, or targeted public‑health programs to address long‑term sequelae.
Finally, measuring the resolution’s impact is an open question. The measure contains no performance metrics or reporting requirements, so any downstream claims of increased diagnosis rates or improved outcomes will depend on separate data collection and analysis undertaken by providers or advocacy coalitions rather than by the state.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.